Talis Biomedical Corporation - Rasio total nilai perusahaan marang pendapatan TLIS

Talis Biomedical (TLIS) - logo korporat

Patent protection of IT systems and strict FDA control establish the foundation for the EV/Sales multiple dynamics, where represents the current metric level for Talis Biomedical (TLIS). Revenue growth is driven by cloud-based rapid testing services. Stable supplies of consumables eliminate logistical disruptions. The smoothness of this chart indicates that the business has reached a maturity stage and that speculative influence on market value has diminished.

Multiplikator EV/Sales Talis Biomedical (TLIS): kanggo periode 04.07.2022 - 19.11.2026

Rincian metrik keuangan lan pasar Talis Biomedical Corporation (TLIS)

- rega saham lan konsensus proyeksi valuasi:
Pambiji fundamental perusahaan:TLIS, Talis Biomedical Corp
Barang unggulan talis.bio

This indicator compares the total enterprise value to annual sales, excluding the impact of debt obligations to determine an objective market valuation of the asset. The price-to-sales ratio trend for Talis Biomedical (TLIS) allows for an assessment of the company's resilience to reagent and chip supply disruptions, where a sharp spike in the line signals overvaluation, while a decline indicates a risk of capital impairment.

Analisis pesaing

Rasio total nilai perusahaan marang pendapatan Abbott Laboratories ABT|TMO: Multiplikator EV/Sales|GEHC - Rasio total nilai perusahaan marang pendapatan|MTD (Mettler-Toledo) - Multiplikator EV/Sales|Multiplikator EV/Sales Waters Technologies|Multiplikator EV/Sales TECH|Multiplikator EV/Sales bruker.com (BRKR)|Rasio nilai perusahaan marang pendapatan Azenta AZTA|Varex - Rasio nilai perusahaan marang pendapatan|SMLR: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan BFLY (Butterfly iQ)|MLAB: Multiplikator EV/Sales|Rasio nilai perusahaan marang dodolan Quantum-Si Incorporated QSI|Rasio nilai perusahaan marang pendapatan nanox.vision|QTRX - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan MASS (908 Devices Inc)|CV: Nilai perusahaan marang volume dodolan|Multiplikator EV/Sales MXCT (maxcyte.com)|Rasio total nilai perusahaan marang pendapatan Rapid Micro Biosystems (RPID)|SEER - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang volume dodolan HYPR|FONAR Corporation Inc (FONR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Daxor Corp. (DXR)|MDAI (Spectral AI Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Organovo Holdings Inc. VIVS|Rasio nilai perusahaan marang pendapatan Aclarion Corp (ACON)|Akoya - Rasio nilai perusahaan marang pendapatan|ThermoGenesis Holdings - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan TTOO (T2 Biosystems, Inc.)